NanoString Technologies (NSTG) Stock Forecast, Price & News

NanoString Technologies (NASDAQ:NSTG) Frequently Asked Questions

Is NanoString Technologies a buy right now?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for NanoString Technologies in the last year. There are currently 4 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" NanoString Technologies stock.
View analyst ratings for NanoString Technologies or view top-rated stocks.

Are investors shorting NanoString Technologies?

NanoString Technologies saw a increase in short interest during the month of April. As of April 30th, there was short interest totaling 3,620,000 shares, an increase of 31.2% from the April 15th total of 2,760,000 shares. Based on an average daily trading volume, of 736,200 shares, the short-interest ratio is presently 4.9 days. Currently, 8.1% of the shares of the company are short sold.
View NanoString Technologies' Short Interest.

When is NanoString Technologies' next earnings date?

NanoString Technologies is scheduled to release its next quarterly earnings announcement on Wednesday, August 3rd 2022.
View our earnings forecast for NanoString Technologies.

How were NanoString Technologies' earnings last quarter?

NanoString Technologies, Inc. (NASDAQ:NSTG) announced its quarterly earnings results on Tuesday, May, 10th. The biotechnology company reported ($0.86) earnings per share for the quarter, missing the consensus estimate of ($0.53) by $0.33. The biotechnology company earned $31.08 million during the quarter, compared to the consensus estimate of $30.95 million. NanoString Technologies had a negative trailing twelve-month return on equity of 68.57% and a negative net margin of 87.89%. The firm's revenue for the quarter was down 1.7% on a year-over-year basis. During the same quarter in the previous year, the firm earned ($0.62) earnings per share.
View NanoString Technologies' earnings history.

What price target have analysts set for NSTG?

4 analysts have issued 12 month price objectives for NanoString Technologies' shares. Their forecasts range from $30.00 to $70.00. On average, they anticipate NanoString Technologies' stock price to reach $45.67 in the next twelve months. This suggests a possible upside of 185.2% from the stock's current price.
View analysts' price targets for NanoString Technologies or view top-rated stocks among Wall Street analysts.

Who are NanoString Technologies' key executives?

NanoString Technologies' management team includes the following people:

• Mr. R. Bradley Gray, CEO, Pres & Director (Age 45, Pay $1.14M) (LinkedIn Profile)
• Mr. K. Thomas Bailey M.B.A., Chief Financial Officer (Age 53, Pay $638.16k) (LinkedIn Profile)
• Mr. David W. Ghesquiere, Sr. VP of Corp. & Bus. Devel. (Age 55, Pay $598.61k)
• Dr. Joseph M. Beechem, Chief Scientific Officer and Sr. VP of R&D (Age 64, Pay $615.92k) (LinkedIn Profile)
• Mr. Mark A. Winham, Sr. VP of Operations
• Mr. Douglas S. Farrell, VP of Investor Relations & Corp. Communications
• Ms. Kathryn Surace-Smith, Sr. VP of HR & Legal Affairs and Corp. Sec. (Age 63)
• Dr. Mary Tedd Allen, Sr. VP of Strategic Initiatives (Age 59)
• Dr. Philippa Webster Ph.D., Sr. Principal Scientist
• Mr. John D. Gerace, Chief Commercial Officer

What is Brad Gray's approval rating as NanoString Technologies' CEO?

36 employees have rated NanoString Technologies CEO Brad Gray on Glassdoor.com. Brad Gray has an approval rating of 65% among NanoString Technologies' employees.

Who are some of NanoString Technologies' key competitors?

Some companies that are related to NanoString Technologies include Beam Therapeutics (BEAM), Iovance Biotherapeutics (IOVA), Bavarian Nordic A/S (BVNRY), Fate Therapeutics (FATE), Twist Bioscience (TWST), Relay Therapeutics (RLAY), SpringWorks Therapeutics (SWTX), BioCryst Pharmaceuticals (BCRX), ImmunityBio (IBRX), Vaxcyte (PCVX), Krystal Biotech (KRYS), Immunocore (IMCR), Exscientia (EXAI), Valneva (VALN) and Vericel (VCEL).
View all of NSTG's competitors.

What other stocks do shareholders of NanoString Technologies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other NanoString Technologies investors own include CA (CA), BlackRock (BLK), Endologix (ELGX), Aegean Marine Petroleum Network (ANW), Chipotle Mexican Grill (CMG), Precision Drilling (PD), AutoZone (AZO), Designer Brands (DBI), Bank of the Ozarks (OZRK) and Vista Outdoor (VSTO).

What is NanoString Technologies' stock symbol?

NanoString Technologies trades on the NASDAQ under the ticker symbol "NSTG."

Who are NanoString Technologies' major shareholders?

NanoString Technologies' stock is owned by many different retail and institutional investors. Top institutional investors include Wellington Management Group LLP (11.43%), BlackRock Inc. (9.31%), Vanguard Group Inc. (7.31%), Invesco Ltd. (3.57%), Polar Capital Holdings Plc (3.48%) and Alyeska Investment Group L.P. (3.11%). Company insiders that own NanoString Technologies stock include Charles P Waite Jr, Elisha W Finney, Gregory Norden, J Chad Brown, Joseph M Beechem, K Thomas Bailey, Kirk Malloy, R Bradley Gray and Robert Hershberg.
View institutional ownership trends for NanoString Technologies.

Which institutional investors are selling NanoString Technologies stock?

NSTG stock was sold by a variety of institutional investors in the last quarter, including Assenagon Asset Management S.A., Wellington Management Group LLP, RTW Investments LP, TimesSquare Capital Management LLC, BlackRock Inc., Vanguard Group Inc., Connacht Asset Management LP, and Dimensional Fund Advisors LP. Company insiders that have sold NanoString Technologies company stock in the last year include Elisha W Finney, Joseph M Beechem, K Thomas Bailey, Kirk Malloy, and R Bradley Gray.
View insider buying and selling activity for NanoString Technologies or view top insider-selling stocks.

Which institutional investors are buying NanoString Technologies stock?

NSTG stock was purchased by a variety of institutional investors in the last quarter, including Polar Capital Holdings Plc, Alyeska Investment Group L.P., Goldman Sachs Group Inc., Invesco Ltd., State Street Corp, Granite Investment Partners LLC, TD Asset Management Inc., and B. Metzler seel. Sohn & Co. AG.
View insider buying and selling activity for NanoString Technologies or or view top insider-buying stocks.

How do I buy shares of NanoString Technologies?

Shares of NSTG can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is NanoString Technologies' stock price today?

One share of NSTG stock can currently be purchased for approximately $16.01.

How much money does NanoString Technologies make?

NanoString Technologies has a market capitalization of $743.12 million and generates $145.09 million in revenue each year. The biotechnology company earns $-115.25 million in net income (profit) each year or ($2.79) on an earnings per share basis.

How many employees does NanoString Technologies have?

NanoString Technologies employs 766 workers across the globe.

What is NanoString Technologies' official website?

The official website for NanoString Technologies is www.nanostring.com.

How can I contact NanoString Technologies?

NanoString Technologies' mailing address is 530 FAIRVIEW AVENUE NORTH SUITE 2000, SEATTLE WA, 98109. The biotechnology company can be reached via phone at (888) 358-6266, via email at [email protected], or via fax at 206-378-6288.